ArticleThe journal of pathology. Clinical research2016

HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat.

Michaela Angelika Ihle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.